DrugPatentWatch Database Preview

HALOTEX Drug Profile

« Back to Dashboard

Which patents cover Halotex, and what generic alternatives are available?

Halotex is a drug marketed by Westwood Squibb and is included in two NDAs.

The generic ingredient in HALOTEX is haloprogin. There is one drug master file entry for this compound. Additional details are available on the haloprogin profile page.

Summary for HALOTEX

US Patents:	0
Applicants:	1
NDAs:	2
Bulk Api Vendors:	18
Patent Applications:	1,614
Drug Prices:	see details
DailyMed Link:	HALOTEX at DailyMed

Synonyms for HALOTEX

(3-Iod-2-propinyl)-(2,4,5-trichlorphenyl)ether

1,2,4-Trichloro-5-(3-iodo-prop-2-ynyloxy)-benzene

1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene

1,2,4-trichloro-5-(3-iodoprop-2-ynyloxy)benzene

1,2,4-trichloro-5-[(3-iodo-2-propynyl) oxy]benzene

1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene

2,4,5-Trichlorophenyl .gamma.-iodopropargil ether

2,4,5-Trichlorophenyl .gamma.-iodopropargyl ether

2,4,5-Trichlorophenyl gamma-iodopropargil ether

2,4,5-Trichlorophenyl iodopropargyl ether

2,4,5-Trichlorophenyl-gamma-iodopropargyl ether

2,5-Trichlorophenyl .gamma.-iodopropargil ether

2,5-Trichlorophenyl .gamma.-iodopropargyl ether

2,5-Trichlorophenyl iodopropargyl ether

3-Iodo-2-propynyl 2,4,5-trichlorophenyl ether

3-Iodo-2-propynyl 2,5-trichlorophenyl ether

777-11-7

777H117

AC1L1G7Q

AC1Q3I91

AIU7053OWL

AKOS030627167

aloprogen

AN-47592

API0008981

BDBM50194601

Benzene, 1,2,4-trichloro-5-((3-iodo-2-propynyl)oxy)-

Benzene, 1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]-

Benzene,1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]

Benzene,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]-

BRD-K13238168-001-01-2

BRN 1976771

C9H4Cl3IO

CAS-777-11-7

CCG-220402

CHEBI:5614

CHEBI:94512

CHEMBL1289

component of Halotex

CTETYYAZBPJBHE-UHFFFAOYSA-N

D00339

D06ZAY

DB00793

DivK1c_000762

DSSTox_CID_26865

DSSTox_GSID_46865

DSSTox_RID_81972

DTXSID9046865

EINECS 212-286-6

Ether, 3-iodo-2-propynyl 2,4,5-trichlorophenyl

Ether,4,5-trichlorophenyl

FCH1325214

Haloprogen

haloprogin

Haloprogin (JAN/USAN/INN)

Haloprogin [USAN:INN:JAN]

Haloprogina

Haloprogina [INN-Spanish]

Haloprogine

Haloprogine [INN-French]

Haloproginum

Haloproginum [INN-Latin]

Halotex (Salt/Mix)

Halotex (TN)

HMS502G04

IDI1_000762

KBio1_000762

KBio2_002365

KBio2_004933

KBio2_007501

KBioSS_002369

LS-67855

M 1028

M-1028 (Meiji)

Mycanden

Mycanden (TN)

Mycilan

Mycilan (TN)

NCGC00181134-01

NCGC00181134-02

NINDS_000762

NSC 100071

NSC-100071

NSC100071

OR070134

OR340497

Polik

Polik (TN)

Prestwick_232

SCHEMBL3649

Spectrum_001852

Tox21_112741

UNII-AIU7053OWL

WLN: I1UU2OR BG DG EG

Z3201

ZINC1530649

US Patents and Regulatory Information for HALOTEX

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Westwood Squibb	HALOTEX	haloprogin	CREAM;TOPICAL	016942-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Westwood Squibb	HALOTEX	haloprogin	SOLUTION;TOPICAL	016943-001	Approved Prior to Jan 1, 1982		DISCN	No	No